248 related articles for article (PubMed ID: 22245114)
21. Combining Real-Time COLD- and MAMA-PCR TaqMan Techniques to Detect and Quantify R201 GNAS Mutations in the McCune-Albright Syndrome
.
de Sanctis L; Galliano I; Montanari P; Matarazzo P; Tessaris D; Bergallo M
Horm Res Paediatr; 2017; 87(5):342-349. PubMed ID: 28334704
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
[TBL] [Abstract][Full Text] [Related]
23. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
24. Two cases of Mazabraud syndrome and identification of a GNAS R201H mutation by next-generation sequencing.
Cox JL; Cushman-Vokoun AM; McGarry SV; Kozel JA
Virchows Arch; 2017 May; 470(5):589-593. PubMed ID: 28258512
[No Abstract] [Full Text] [Related]
25. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome.
Karadag A; Riminucci M; Bianco P; Cherman N; Kuznetsov SA; Nguyen N; Collins MT; Robey PG; Fisher LW
Nucleic Acids Res; 2004 Apr; 32(7):e63. PubMed ID: 15096559
[TBL] [Abstract][Full Text] [Related]
26. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
[TBL] [Abstract][Full Text] [Related]
27. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
28. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
[TBL] [Abstract][Full Text] [Related]
30. Detection of Rare Somatic GNAS Mutation in McCune-Albright Syndrome Using a Novel Peptide Nucleic Acid Probe in a Single Tube.
Lo FS; Chen TL; Chiou CC
Molecules; 2017 Nov; 22(11):. PubMed ID: 29104223
[TBL] [Abstract][Full Text] [Related]
31. Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.
Hartley I; Zhadina M; Collins MT; Boyce AM
Calcif Tissue Int; 2019 May; 104(5):517-529. PubMed ID: 31037426
[TBL] [Abstract][Full Text] [Related]
32. Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.
Patel MM; Wilkey JF; Abdelsayed R; D'Silva NJ; Malchoff C; Mallya SM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):739-43. PubMed ID: 20346714
[TBL] [Abstract][Full Text] [Related]
33. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
Shenker A; Weinstein LS; Sweet DE; Spiegel AM
J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
[TBL] [Abstract][Full Text] [Related]
34. Analysis of GNAS1 mutations in myxoid soft tissue and bone tumors.
Walther I; Walther BM; Chen Y; Petersen I
Pathol Res Pract; 2014 Jan; 210(1):1-4. PubMed ID: 24268734
[TBL] [Abstract][Full Text] [Related]
35. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
[TBL] [Abstract][Full Text] [Related]
36. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
37. Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization.
Toyosawa S; Yuki M; Kishino M; Ogawa Y; Ueda T; Murakami S; Konishi E; Iida S; Kogo M; Komori T; Tomita Y
Mod Pathol; 2007 Mar; 20(3):389-96. PubMed ID: 17334331
[TBL] [Abstract][Full Text] [Related]
38. [The activating GNAS mutation : A survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions].
Ostertag H; Glombitza S
Pathologe; 2018 Mar; 39(2):146-153. PubMed ID: 29488004
[TBL] [Abstract][Full Text] [Related]
39. McCune Albright syndrome and bilateral adrenal hyperplasia: the GNAS mutation may only be present in adrenal tissue.
Angelousi A; Fencl F; Faucz FR; Malikova J; Sumnik Z; Lebl J; Stratakis CA
Hormones (Athens); 2015; 14(3):447-50. PubMed ID: 26188235
[TBL] [Abstract][Full Text] [Related]
40. Activating GNAS1 gene mutations in patients with premature thelarche.
Román R; Johnson MC; Codner E; Boric MA; áVila A; Cassorla F
J Pediatr; 2004 Aug; 145(2):218-22. PubMed ID: 15289771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
